Authors:
Everse, LA
Anderson, LD
van Rooijen, N
Mullen, CA
Citation: La. Everse et al., Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate GVHD and increases peri-BMT mortality, TRANSPLANT, 71(5), 2001, pp. 611-618
Authors:
Bernsen, MR
Tang, JW
Everse, LA
Koten, JW
Den Otter, W
Citation: Mr. Bernsen et al., Interleukin 2 (IL-2) therapy: potential advantages of locoregional versus systemic administration, CANC TR REV, 25(2), 1999, pp. 73-82
Authors:
Den Otter, W
Balemans, L
Battermann, JJ
Bernsen, MR
Cadee, JA
Dobrowolski, Z
Everse, LA
Fiszer-Maliszewska, L
Gavhumende, R
De Groot, JW
De Groot, K
Hennink, WE
Hill, FWG
Jurgenliemp-Schulz, I
Klein, WR
Koten, JW
Maas, RA
Steerenberg, P
Stewart, R
Zembala, M
Citation: W. Den Otter et al., Local low-dose IL-2 therapy, HEP-GASTRO, 46, 1999, pp. 1280-1286
Authors:
Anderson, LD
Petropoulos, D
Everse, LA
Mullen, CA
Citation: Ld. Anderson et al., Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine, CANCER RES, 59(7), 1999, pp. 1525-1530